TY - JOUR
T1 - Bronchoplastic resection for non-small-cell lung cancer
AU - Müller, C.
AU - Schinkel, C.
AU - Hoffmann, H.
AU - Dienemann, H.
AU - Schildberg, F. W.
PY - 1996/10
Y1 - 1996/10
N2 - During the past 12 years, among 1478 operations for non-small-cell lung cancer (NSCLC), 102 (6.9%) bronchosplastic resections were performed. There were 74 lobectomies, 19 bilobectomies, and 9 pneumonectomies done by means of 72 sleeve-, 28 wedge resections, and 2 resections of the tracheal bifurcation. Atelectasis was observed in 6%, whereas anastomotic dehiscence occurred in 4%. Local complete resection was achieved in 81%. The 30-day mortality amounted to 4%. Our results demonstrate that bronchoplastic procedures represent a safe therapeutic option in the operative treatment of central NSCLC.
AB - During the past 12 years, among 1478 operations for non-small-cell lung cancer (NSCLC), 102 (6.9%) bronchosplastic resections were performed. There were 74 lobectomies, 19 bilobectomies, and 9 pneumonectomies done by means of 72 sleeve-, 28 wedge resections, and 2 resections of the tracheal bifurcation. Atelectasis was observed in 6%, whereas anastomotic dehiscence occurred in 4%. Local complete resection was achieved in 81%. The 30-day mortality amounted to 4%. Our results demonstrate that bronchoplastic procedures represent a safe therapeutic option in the operative treatment of central NSCLC.
KW - NSCLC
KW - bronchoplastic resection
UR - http://www.scopus.com/inward/record.url?scp=0029861488&partnerID=8YFLogxK
U2 - 10.1055/s-2007-1012029
DO - 10.1055/s-2007-1012029
M3 - Article
C2 - 8948553
AN - SCOPUS:0029861488
SN - 0171-6425
VL - 44
SP - 248
EP - 251
JO - Thoracic and Cardiovascular Surgeon
JF - Thoracic and Cardiovascular Surgeon
IS - 5
ER -
